Keyphrases
Cystic Fibrosis
100%
Patient Assessment
100%
Gastrointestinal Outcomes
100%
Elexacaftor-tezacaftor-ivacaftor
100%
Gastrointestinal Diseases
50%
Constipation Symptoms
50%
Upper Gastrointestinal Symptoms
50%
Patient Assessment of Constipation Quality of Life
50%
Fecal Calprotectin
33%
Prospective Observational Study
16%
Quality of Life
16%
Symptom Assessment
16%
Validated Questionnaire
16%
Inflammation Markers
16%
Confidence Interval
16%
Clinical Significance
16%
F508del
16%
Pulmonary Disease
16%
Linear Regression
16%
Elastase-1
16%
Pancreatic Insufficiency
16%
Fecal Markers
16%
Fecal Elastase
16%
High-score
16%
Medicine and Dentistry
Cystic Fibrosis
100%
Ivacaftor
100%
Patient Assessment
100%
Tezacaftor
100%
Constipation
66%
Quality of Life
44%
Gastrointestinal Disease
33%
Gastrointestinal Distress
33%
Faecal Calprotectin
22%
Elastase
22%
Observational Study
11%
Silo-Filler's Disease
11%
Linear Regression Analysis
11%
Pancreatic Insufficiency
11%
Allele
11%
Effect Size
11%